(Q46472687)

22 December 2017

title

Pharmacokinetic interaction between pravastatin and olmesartan in relation to SLCO1B1 polymorphism (English)

1 reference

22 December 2017

1 reference

Suttasinee Suwannakul

1

1 reference

22 December 2017

Ichiro Ieiri

2

1 reference

22 December 2017

Miyuki Kimura

3

1 reference

22 December 2017

Kiyoshi Kawabata

4

1 reference

22 December 2017

Hiroyuki Kusuhara

5

1 reference

22 December 2017

Takeshi Hirota

6

1 reference

22 December 2017

Shin Irie

7

1 reference

22 December 2017

Yuichi Sugiyama

8

1 reference

22 December 2017

Shun Higuchi

9

1 reference

22 December 2017

publication date

19 July 2008

1 reference

22 December 2017

Journal of Human Genetics

published in

1 reference

22 December 2017

volume

53

1 reference

22 December 2017

page(s)

899-904

1 reference

22 December 2017

issue

10

1 reference

22 December 2017

https://scigraph.springernature.com/pub.10.1007/s10038-008-0324-9

exact match

0 references

cites work

Evidence for inverse effects of OATP-C (SLC21A6) 5 and 1b haplotypes on pravastatin kinetics

1 reference

12 December 2020

Polymorphic organic anion transporting polypeptide 1B1 is a major determinant of repaglinide pharmacokinetics

1 reference

12 December 2020

Human liver-specific organic anion transporter, LST-1, mediates uptake of pravastatin by human hepatocytes.

1 reference

12 December 2020

OATP1B1, OATP1B3, and mrp2 are involved in hepatobiliary transport of olmesartan, a novel angiotensin II blocker

1 reference

12 December 2020

Biotransformation of pravastatin sodium in humans

1 reference

12 December 2020

High plasma pravastatin concentrations are associated with single nucleotide polymorphisms and haplotypes of organic anion transporting polypeptide-C (OATP-C, SLCO1B1)

1 reference

12 December 2020

Comparative pharmacokinetic interaction profiles of pravastatin, simvastatin, and atorvastatin when coadministered with cytochrome P450 inhibitors

1 reference

12 December 2020

Bile salt export pump (BSEP/ABCB11) can transport a nonbile acid substrate, pravastatin

1 reference

12 December 2020

Quantitative determination of pravastatin and R-416, its main metabolite in human plasma, by liquid chromatography-tandem mass spectrometry

1 reference

12 December 2020

Effects of acid and lactone forms of eight HMG-CoA reductase inhibitors on CYP-mediated metabolism and MDR1-mediated transport.

1 reference

12 December 2020

Effect of fluconazole on plasma fluvastatin and pravastatin concentrations

1 reference

12 December 2020

Functional analysis of single nucleotide polymorphisms of hepatic organic anion transporter OATP1B1 (OATP-C).

1 reference

12 December 2020

Effects of grapefruit juice on pharmacokinetics of atorvastatin and pravastatin in Japanese

1 reference

12 December 2020

Polymorphisms of OATP-C (SLC21A6) and OAT3 (SLC22A8) genes: consequences for pravastatin pharmacokinetics

1 reference

12 December 2020

The pharmacokinetic and metabolic profile of olmesartan medoxomil limits the risk of clinically relevant drug interaction.

1 reference

12 December 2020

Involvement of human organic anion transporting polypeptide OATP-B (SLC21A9) in pH-dependent transport across intestinal apical membrane.

1 reference

12 December 2020

Disposition of oral and intravenous pravastatin in MRP2-deficient TR- rats

1 reference

12 December 2020

Effect of OATP1B1 (SLCO1B1) variant alleles on the pharmacokinetics of pitavastatin in healthy volunteers.

1 reference

12 December 2020

Functional characterization of SLCO1B1 (OATP-C) variants, SLCO1B1*5, SLCO1B1*15 and SLCO1B1*15+C1007G, by using transient expression systems of HeLa and HEK293 cells

1 reference

12 December 2020

SLCO1B1 (OATP1B1, an uptake transporter) and ABCG2 (BCRP, an efflux transporter) variant alleles and pharmacokinetics of pitavastatin in healthy volunteers

1 reference

12 December 2020

Effects of organic anion transporting polypeptide 1B1 haplotype on pharmacokinetics of pravastatin, valsartan, and temocapril

1 reference

12 December 2020

Multiple human isoforms of drug transporters contribute to the hepatic and renal transport of olmesartan, a selective antagonist of the angiotensin II AT1-receptor

1 reference

12 December 2020

Functional involvement of rat organic anion transporter 3 (rOat3; Slc22a8) in the renal uptake of organic anions

1 reference

12 December 2020

Fexofenadine pharmacokinetics are associated with a polymorphism of the SLCO1B1 gene (encoding OATP1B1)

1 reference

12 December 2020

Genetic polymorphisms of human organic anion transporters OATP-C (SLC21A6) and OATP-B (SLC21A9): allele frequencies in the Japanese population and functional analysis

1 reference

12 December 2020

Polymorphisms in OATP-C: identification of multiple allelic variants associated with altered transport activity among European- and African-Americans

1 reference

12 December 2020

10.1007/S10038-008-0324-9

Identifiers

DOI

1 reference

22 December 2017

PubMed ID

18641915

1 reference

22 December 2017